The Susan G. Komen for the Cure® Brinker Awards for Scientific Distinction in Basic Science and Clinical Research will be presented to Hyman B. Muss, MD, Professor of Medicine and the Director of the Geriatric Oncology Program at University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, and Yosef Yarden, PhD, of the Harold and Zelda Goldenberg Professor of Molecular Cell Biology at the Weizmann Institute of Science in Rehovot, Israel.
Dr. Muss is receiving the Brinker Award for Scientific Distinction in Clinical Research for his critical contributions to the treatment of breast cancer, in particular the treatment of breast cancer in older women. His work on clinical trials specifically targeted to older women has provided the foundation for offering geriatric patients state-of-the art treatments and has had a significant impact on the standard of care and quality of life for elderly women with breast cancer.
Professor Yarden is receiving the Brinker Award for Scientific Distinction in Basic Science for his extensive contributions to breast cancer research, which have been instrumental in advancing our understanding of the biology of growth factors and their receptors, and their role in human cancers. His research has been crucial to establishing growth factor receptors—particularly the HER2 receptor—as prime targets for cancer drugs.
Dr. Muss and Dr. Yarden will deliver keynote lectures on December 5 at the 35th annual San Antonio Breast Cancer Symposium. Watch for coverage of this important symposium in the next issue of The ASCO Post. ■
